Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis

Calcified Tissue International

Volumn 76, Issue 3, 2005, Pages 176-186

  Richy, F ^a   Schacht, E ^b   Bruyere, O ^a   Ethgen, O ^a   Gourlay, M ^c   Reginster, J Y ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Alfacalcidol; Bone; Calcitriol; Fractures; Meta analysis; Osteoporosis; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CORTICOSTEROID; 1-HYDROXYCHOLECALCIFEROL; HYDROXYCOLECALCIFEROL; VITAMIN D;

ARTICLE; BONE DENSITY; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMBASE; FEMUR NECK; FRACTURE; GENETIC HETEROGENEITY; HUMAN; LUMBAR SPINE; MEDLINE; META ANALYSIS; METHODOLOGY; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SPINE FRACTURE; SYSTEMATIC REVIEW; TIME; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; BONE DENSITY; CALCITRIOL; FEMALE; FRACTURES, BONE; HUMANS; HYDROXYCHOLECALCIFEROLS; MALE; MIDDLE AGED; OSTEOPOROSIS; TREATMENT OUTCOME; VITAMIN D;

EID: 21344472972     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0005-4     Document Type: Article

References (50)

1. Gillespie WJ, Avenell A, Henry DA, O'Connell DL (2001) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 1:CD000227
2. Hauselmann HJ, Rizzoli R (2003) A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 14:2-12
3. Cranney A, Guyatt G, Griffith L, Wells G (2002) IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570-578
4. Padimitropoulos E, Wells G, Shea B, Gillespie W (2002) VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560-569
5. Papadimitropoulos E, Shea B, Wells G, Tugwell P, et al. (2002) Vitamin D with or without calcium for treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev
6. Lau KH, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 65:295-306
7. Tsai KS, Heath H III, Kumar R, Riggs BL (1984) Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668-1672
8. Scopacasa F, Wishart JM, Horowitz M (2004) Relation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to calcitriol. Eur J Clin Nutr 58:264-269
9. Pattanaungkul S, Riggs BL, Yergey AL (2000) Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 85:4023-4027
10. Dickersin K, Scherer R, Lefebvre C (1994) Identifying the relevant studies for systematic reviews. BMJ 309:1286-1291
11. Jadad AR, Moore RA, Carroll D, Jenkinson C (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
12. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
13. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082
14. Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, et al. (1998) HRT and vitamin D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 31:45-54
15. Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, et al. (1999) Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 84:546-552
16. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C (2000) Effects of a short-term vitamin D and calcium supplementation on body smay and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113-1118
17. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 115:505-512
18. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676
19. Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JI (2002) Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 17:709-715
20. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 124:400-406
21. Ooms ME, Roos JC, Bezemer PD, Van Der Vijgh WJF, Bouter LM, Lips P (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058
22. Hunter D, Major P, Arden N, Swaminathan R, Andrew T, et al. (2000) A randomized controlled trial of vitamin D supplementation on preventing post menopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner Res 15:2276-2283
23. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469-472
24. Baeksgaard L, Andersen KP, Hyldstrup L (1998) Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporos Int 8:255-260
25. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1996) Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125:961-968
26. Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, et al. (1996) Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheum 23:995-1000
27. Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, et al. (1996) A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 10:777-786
28. Ushiroyama T, Okamura S, Ikeda A, Ueki M (1995) Efficacy of ipriflavone and 1α vitamin D therapy for the cessation of vertebral bone loss. Int J Gynecol Obstet 48:283-288
29. Hayashi Y, Fujita T, Inoue T (1992) Decrease of vertebral fracture in osteoporosis by administration of 1α-hydroxyvitamin D3. J Bone Min Res 10:184-188
30. Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, et al. (2000) Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Z Rheumatol 59suppl 1:48-52
31. Menczel J, Foldes J, Steinberg R, Leichter I, Shalita B, et al. (1994) Alfacalcidol(Alpha D3) and calcium in osteoporosis. Clin Orthop 300:241-247
32. Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T (1994) Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370-376
33. Reginster JY, Kuntz D, Verdicht W, Wouters M, Guillevin L, et al. (1999) Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Bone 9:75-81
34. Sato Y, Manabe S, Kuno H, Oizumi K (1999) Amelioration of osteopenia and hypovitaminosis D by 1a-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurosurg Psychiatry 66:64-68
35. Sato Y, Maruoka H, Oizumi K (1997) Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1a-hydroxyvitamin D3 and calcium supplementation. Stroke 28:736-739
36. Shiraki M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2 year's treatment of osteoporosis with 1a-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43:211-220
37. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn S (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401-408
38. Ebeling PR, Wark JD, Yeung S, Poon C, Salehi N, et al. (2001) Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-years randomized, double blind, double placebo study. J Clin Endocr Metab 86:4096-4103
39. Gallagher JC, Riggs BL, Recker RR, Goldgar D (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Soc Exp Biol Med pp 287-292
40. Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618-3628
41. Gallagher JC, Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113:649-655
42. Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW (2000) Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double-blind, placebo controlled study. J Rheumatol 27:1759-1765
43. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, et al. (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752
44. Sambrook P, Henderson NK, Keogh A, Maodonald P, Glanville A, Spratt P (2000) Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Min Res 15:1818-1824
45. Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol and calcium. N Engl J Med 326:357-362
46. Stempfle HU, Werner C, Echtler S, Wehr U, Rambeck WA, et al. (1999) Prevention of osteoporosis after cardiac transplantation. Transplantation 68:523-530
47. Ringe JD. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis Unpublished data.
48. Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, et al. (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Min Res 18:919-924
49. Bucher HC, Guyatt GH, Griffith L, Walter SD (1997) The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50:683-691
50. Song F, Altman DG, Glenny AM, Deeks JJ (2003) Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 326:472